Molecular Diagnostics Collaboration and Licensing Deals 2016-2024

Molecular Diagnostics Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2016
•    Browse molecular diagnostics collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in molecular diagnostics dealmaking
2.1. Introduction
2.2. Molecular diagnostics deals over the years
2.3. Most active molecular diagnostics dealmakers
2.4. Molecular diagnostics deals by deal type
2.5. Molecular diagnostics deals by therapy area
2.6. Molecular diagnostics deals by industry sector
2.7. Deal terms for molecular diagnostics deals
2.7.1 Molecular diagnostics deals headline values
2.7.2 Molecular diagnostics deal upfront payments
2.7.3 Molecular diagnostics deal milestone payments
2.7.4 Molecular diagnostics royalty rates

Chapter 3 – Leading molecular diagnostics deals
3.1. Introduction
3.2. Top molecular diagnostics deals by value

Chapter 4 – Most active molecular diagnostics dealmakers
4.1. Introduction
4.2. Most active molecular diagnostics dealmakers
4.3. Most active molecular diagnostics deals company profiles

Chapter 5 – Molecular diagnostics contracts dealmaking directory
5.1. Introduction
5.2. Molecular diagnostics contracts dealmaking directory

Chapter 6 – Molecular diagnostics dealmaking by technology type

Deal directory

Deal directory – Molecular diagnostics deals by company A-Z
Deal directory – Molecular diagnostics deals by deal type
Deal directory – Molecular diagnostics deals by therapy area

Deal type definitions

About Biopharma Research Ltd 
Current Partnering
Current Agreements
Recent report titles from Current Partnering

 
Table of figures

Figure 1: Molecular diagnostics deals since 2016
Figure 2: Active molecular diagnostics dealmaking activity – 2016 - 2024
Figure 3: Molecular diagnostics deals by deal type since 2016
Figure 4: Molecular diagnostics deals by therapy area since 2016
Figure 5: Molecular diagnostics deals by industry sector since 2016
Figure 6: Molecular diagnostics deals with a headline value
Figure 7: Molecular diagnostics deals with an upfront value
Figure 8: Molecular diagnostics deals with a milestone value
Figure 9: Molecular diagnostics deals with a royalty rate value
Figure 10: Top molecular diagnostics deals by value since 2016
Figure 11: Most active molecular diagnostics dealmakers 2016 - 2024
Figure 12: Molecular diagnostics deals by technology type since 2016

Pricing options

• $3,995: single-user (encrypted file - one user/device)
• $5,995: multi-user (encrypted file - up to 5 users/devices)
• $7,995: company (unencrypted PDF)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

2bPrecise, 2cureX, 4bases, 4D Path, 10X Genomics, 23andMe, 221b Foundation, Academic Breast Cancer Consortium, Accelerate Technologies, AccuGenomics, AccuStem Sciences, AchilleS Vaccines, Acumen Diagnostics, Adaptive Biotechnologies, Adiso Therapeutics, Aditx Therapeutics, Admera Health, ADT Altona Diagnostic Technologies, Advanced Cell Diagnostics, Aegea Biotechnologies, Age Labs, Agena Bioscience, Agendia, Agilent Technologies, Agios Pharmaceuticals, Akonni Biosystems, Akoya Biosciences, Alamar Biosciences, Alberta Health Services, Albertsons Companies, ALBOT Technologies, Aldeyra Therapeutics, Alibaba Health, Allelica, Almac Diagnostics, Alnylam Pharmaceuticals, Alphazyme, Alveo Technologies, Alzheimer's Drug Discovery Foundation, Alzheon, Amazon Web Services, Ambry Genetics, Amgen, Amoy Diagnostics, AnchorDx, Angle, AnHeart Therapeutics, Anixa Biosciences, Anpac Bio-Medical Science, AnteoTech, Antisoma Therapeutics, Apollomics, Aptamer Therapeutics, Aptitude Medical Systems, Aptorum Group, Arbor Biosciences, ArcherDX, Ares Genetics, Ares Life Sciences, Arisan Therapeutics, Arizona State University, Artidis, Asep Medical, Ashion Analytics, Assistance Publique-Hôpitaux de Paris, Astellas Pharma, Asterand Bioscience, Asthma UK, AstraZeneca, Atlas Antibodies, Atrin Pharmaceuticals, Avacta, Avera Health, AXIM Biotechnologies, Babson Diagnostics, Baebies, BAMF Health, Bay Area Lyme Foundation, Bayer, Baylor Scott and White Research Institute, BC Neuroimmunology, BC Platforms, Beckman Coulter, Becton Dickinson, BeiGene, Beijing Genomics Institute (BGI), Berg, Berkeley Lights, Beroni Group, Berry Genomics, Berry Oncology, Be The Match BioTherapies, BGN Technologies, Bicycle Therapeutics, Big Eye Diagnostics, Bill and Melinda Gates Foundation, Bio-Me, Bio-Rad Laboratories, Bio-Techne, bioAffinity Technologies, BioAge Labs, BIOASTER, Biocartis, Biocept, BioCheetah, Biocodices, Biodesix, Biodirection, BioExcel Diagnostics, Biofidelity, BioGemex, Biogenar, Biognosys, BioGX, BioInvent, BioIQ, Biological Dynamics, BioMark Diagnostics, Biomedical Advanced Research and Development Authority, Biomeme, Biomerica, Biomillenia, BioNano Genomics, Biosearch Technologies, BioSkryb, BioSure, BL&H, Blu Biotech, Blue Cross Blue Shield Association, Blueprint Genetics, Boehringer Ingelheim, Boreal Genomics, Bosch, BostonGene, Brahms, Brandeis University, Brazlex Medical Genetics, Breath Diagnostics, Bredis Healthcare, Brigham and Women's Hospital, BrightPath Biotherapeutics, Bristol-Myers Squibb, Broad Institute, Brotman-Baty Institute, Bruker, Burning Rock, BurstIQ, C2i Genomics, C2Sense, Calviri, Cambridge Enterprise, Cambridge Epigenetix, Canadian Cancer Society, Canadian Institutes of Health Research, Cancer Research Institute, CancerX initiative, Cantabio Pharmaceuticals, Capsulomics, CARB-X, Cardea Bio, Cardiff University, CareDx, CareFirst BlueCross BlueShield, Caris Life Sciences, Carpegen, Case Western Reserve University, Castle Biosciences, CeGaT, Celcuity, Celgene, Cellgen Diagnostics, Cell Guidance Systems, CellMax Life, Cell Microsystems, Cellpath, Celsius Therapeutics, Cenetron, Centers for Disease Control and Prevention, Centogene, Centre Leon Berard, Cepheid, Cerba HealthCare, Cerveau Technologies, Charcot-Marie-Tooth Association, Charles River Laboratories, Chembio Diagnostics, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital Los Angeles, Children's Hospital of Orange County, Christian Doppler Research Association, ChromaCode, Chronix Biomedical, Chubu University, Cicero Diagnostics, Cipla, Circulogene, City of Hope, CK Life Sciences, Clarity Pharmaceuticals, Clearbridge Biomedics, ClearNote Health, Cleveland Clinic, Cleveland Diagnostics, Cleveland University Hospitals, CloudHealth Genomics, CND Life Sciences, Co-Diagnostics, Codexis, Coeptis Pharmaceuticals, Cofactor Genomics, Colorado Melanoma Foundation, Columbia University, Companion Medical, Concert Genetics, Congenica, Contextual Genomics, Cooper Companies, Copenhagen University Hospital, CoreBiome, Coriell Life Sciences, Cornell University, Corteva Agriscience, Covance, Cradle Genomics, CrisprBits, Criterium, CSI Laboratories, Cue Health, Culmination Bio, Cumming, Curetis, Curta, Cypre, Cytox, Daiichi Sankyo, Dana-Farber Cancer Institute, Danish Center for Strategic Research into Type 2 Diabetes, DarioHealth, Dartmouth-Hitchcock Medical Center, DarwinHealth, DCN Diagnostics, Decipher Biosciences, deCODE Genetics, Deep Bio, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Definiens, Dell Medical School, Delphi Diagnostics, Denali Therapeutics, Dendreon, Denso, Department of Defense, Department of Health and Human Services, DermTech, DestiNA Genomics, Devyser Diagnostics, DiaCarta, Diadem, DiamiR, DIAN Diagnostics, Diaprost, DiaSorin, Diatech Pharmacogenetics, Diesse Diagnostica Senese, DNAmito, DoMore Diagnostics, Domus Diagnostics, Drawbridge Health, Duchenne UK, Duke University, DxTerity, DxVx, DYNEX Technologies, E25Bio, EchelonDx, Edico Genome, EDP Biotech, Eisai, Elephas, Elevation Oncology, Eli Lilly, Elucigene, EmeritusDX, Empowered Diagnostics, Enterome Bioscience, Enzyre, Enzyvant Science, Epic, EpicGenetics, Epicore Biosystems, Epic Sciences, Epiphany Dermatology, Epivax, ESSA Pharma, Ethos Laboratories, Ethos Research & Development, Ethos Veterinary Health, Euformatics, Eureka Eurostars, EuroClone, Eurofins Scientific, Euroimmun, European Institute of Oncology (EIO), European Organization for Research and Treatment of Cancer, European Union, Evogen, Evotec, Exact Sciences, Exagen Diagnostics, Exai Bio, Exigent Research, Exosome, Exosome Sciences, Expedeon, Expesicor, ExSeed, F-Star Therapeutics, Factorial Diagnostics, Falco, First Genetics JCS, Flagship Biosciences, Flare Therapeutics, Flatiron Health, FlowMetric, Fluxion Biosciences, FLX Bio, Fondation Cancer, Fondatioun Kriibskrank Kanner, Fortelinea Software Systems, Foundation Medicine, Fox Chase Cancer Center, Fraunhofer Institute for Cell Therapy and Immunology, Freenome, Friends of Cancer Research, Fudan University, Fujirebio Diagnostics, Fulgent Genetics, Fundacion Progreso y Salud, Fusion Genomics, FYR Diagnostics, Galectin Therapeutics, GC Genome, Gemini Therapeutics, Gencove, Gene Bio Medical, GeneCentric Therapeutics, GeneDX, GeneNews, Genentech, Geneoscopy, GeneThera, Genetic Alliance, Genetic Analysis, Genetic Technologies, Genetron Health, Genfit, Genolution, Genome Canada, GenomeDx, Genome Institute of Singapore, Genome Prairie, Genomic Health, Genomic Testing Cooperative, Genomill Health, Genomind, GenoScreen, Genosity, GenScript Biotech, Georgetown University, German Federal Ministry of Education and Research, Gestalt Diagnostics, GI OnDEMAND, Global Access Diagnostics, GNS Healthcare, Good Start Genetics, Government of Canada, Government of South Korea, Grail, Gritstone Bio, Group K Diagnostics, GSK, GSK Consumer Healthcare, Guardant Health, Hackensack Meridian Health, HALO Precision Diagnostics, Hamilton Robotics, Harbinger Health, Harvard University, HEALTH Biomed, Heat Biologics, Hebrew University of Jerusalem, Helio Genomics, Helio Health, Helix, Hemex Health, Henan Cancer Hospital, Hereditary Neuropathy Foundation, HiloProbe, HMicro, Hoag Memorial Hospital Presbyterian, Hologic, Horizon Discovery, Hospital Clinic of Barcelona, HTG Molecular Diagnostics, Hubrecht Organoid Technology, Hummingbird Bioscience, Hummingbird Diagnostics, Ibex Medical Analytics, Icahn School of Medicine at Mount Sinai, ICAN, Idaho Urologic Institute, IDbyDNA, Idengene, Ikonopedia, Illumina, ImageMover, ImaginAb, IMBdx, Imec, ImmunArray, Immunexpress, ImmunID Technologies, ImmunoPrecise Antibodies, Immunovia, Imperial College London, IncellDx, Incyte, InDevR, Indica Labs, Indivumed, Infinity BiologiX, Inflammatix, Informed Data Systems, Inivata, Innoplexus, Innovate UK, Institut Català d'Oncologia, Institut Curie, Institute for Bioscience and Biotechnology Research, Institute for Genome Statistics and Bioinformatics, Institute of Cancer Research, Institute of Human Genetics, Institute of Organic Chemistry and Biochemistry, Institut Gustave Roussy, Institut Paoli-Calmettes, Institut Pasteur, Integrated Biobank of Luxembourg, Integrated Micro-Chromatography Systems, Intermountain Healthcare, International Isotopes, Interpace Diagnostics, Invitae, InVivoScribe, ION Solutions, IRX Therapeutics, IsoPlexis, ISOThrive, ITM Isotopen Technologien, JADBio, Janssen-Cilag, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Agency for Medical Research and Development, Jefferson Healthcare, Jeffrey Modell Foundation, Jiangsu Chia Tai Tianqing Pharmaceutical, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, John Wayne Cancer Institute, Juntendo University, Karolinska Institute, Karolinska University Hospital, KDx Diagnostics, KELTIC Pharma, Kephera Diagnostics, KEW, Kite Pharma, Knight Cancer Institute, Konica Minolta Precision Medicine, Krystal Biotech, Kura Oncology, Labcyte, Laboratory Corporation of America, La Jolla Institute for Allergy & Immunology, LamdaGen, Lantheus Holding, Latvian Institute of Organic Synthesis, Leap Therapeutics, Leica Biosystems, Leicester University, Leinco Technologies, LEO Pharma, Les Laboratoires Servier, LexaGene, Lexent Bio, LifeLabs Medical Laboratory Services, Life Raft Group, LifeX Ventures, Li Ka Shing Foundation, Liquid Biosciences, Little Warrior Foundation, Liverpool School of Tropical Medicine, LogicInk, Longhorn Vaccines and Diagnostics, Lonza, Lorna Linda University, Loxo Oncology, Lucence, Lucid Diagnostics, Luminex, LuminUltra, LumiraDx, Lunit, Lupus Research Alliance, Macrogen, Magellan Healthcare, Magenta Therapeutics, Magnetrap, Mainz Biomed, Mammoth Biosciences, Manhattan Scientifics, Mannin Research, Massachusetts General Hospital, Massachusetts Institute of Technology, Maxim Biomedical, Mayo Clinic, MBio Diagnostics, McMaster University, MD Anderson Cancer Center, MD Biosciences, MDNA Life Sciences, MDxHealth, MEDIAN Technologies, Medical University of Graz, Medical University of Vienna, MediSapiens, Medosome Biotec, MeMed, Memorial Sloan Kettering Cancer Center, Menon Biosensors, Merck and Co, Merck KGaA, Mesa Biotech, Metabiomics, Metabolomic Diagnostics, Metabolon, MGI Pharma, MGI Tech, Michael J Fox Foundation, Michelson Center, Microbix Biosystems, Microsoft, Mie University, Mimetas, MIODx, miR Scientific, MiRXES, MiTest Health, Mobility Health, Moderna, Molbio Diagnostics, Molecular Health, MolecularMD, Molecular Stethoscope, Molecular Targeting Technologies, MolGen, Mologic, Monoceros Biosystems, Montana State University, Moss Genomics, Mount Sinai Health System, MP Group, mProbe Laboratories, MRIGlobal, MRM Proteomics, Multi G, Multiplex Genomics, Muscular Dystrophy Association, Myelopro Diagnostics and Research, Mylab Discovery Solutions, Myriad Genetics, NanoMab Technology, Nanomix, Nanommune, NanoSpot.ai, Nanostics Precision Health, NanoString Technologies, NantHealth, Natera, National Cancer Center, National Cancer Center of Japan, National Cancer Centre Singapore, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal Diseases, National Institute of Biomedical Imaging and Bioengineering, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institutes of Health, National Science Foundation, Natural Sciences and Engineering Research Council of Canada, Naveris, NEC, Nektar Therapeutics, NeoDynamics, Neogap Therapeutics, Neogen, Neogenomics, NeraCare, NeuMoDx Molecular, Neuro Bio, NeuroSense Therapeutics, New England Biolabs, New Horizon Health, NewStem, New York Blood Center, Next Gen Diagnostics, NGeneBio, Nippon Kayaku, Northwestern University, Norwegian Institute of Public Health, Norwegian Research Council, Notable Labs, Novartis, NovellusDx, Novogene, NOWDiagnostics, nRichDX, Nucleai, Nucleix, Numares, NuProbe, NX Prenatal, Ohio State University, Oklahoma Medical Research Foundation, Oligomerix, Olink Proteomics, OmiCure, Oncimmune, OncoCyte, OncoDNA, OncoGenesis, OncoHost, OncoNano Medicine, Oncovet, One BioMed, One Lambda, Ono Pharmaceutical, Ontario Institute for Cancer Research, Ontera, Opentrons Labworks, OpGen, OPKO Health, Opto-Systems, OraSure Technologies, Oregon Health Sciences University, OrigiMed, Orpheus Medical, Ortho-Clinical Diagnostics, Oslo University Hospital, OvuSense, Owlstone Medical, Oxford Nanopore Technologies, Pacific Biosciences, Paige, Pain Therapeutics, Paradigm, Parent Project Muscular Dystrophy, Parexel, Parkway Clinical Laboratories, Passage Bio, PathGroup, Patia, PAVmed, Pennsylvania State University, PeptiDream, PerkinElmer, Personal Genome Diagnostics, Personalis, Perspectum Diagnostics, Pfizer, Pfizer Canada, Pharmacological research Institute Mario Negri, Phase Genomics, Phenomix, Philips, Phillips-Medisize, Phoenix Molecular Designs, PierianDx, Pillar Biosciences, Planet Innovation, Plexision, Point32Health, PPD, Precipio Diagnostics, Precision Diabetes, Precision for Medicine, Precision Pathology Services, Predicine, PredictImmune, Predictive Technology Group, PrediLife, Premier Inc, Prenetics, Prenosis, Preora Diagnostics, Prescient Medical, Prevencio, Previse, Princeton BioMeditech, Progentec Diagnostics, ProMIS Neurosciences, Prophase Labs, Protea Biosciences, Protean BioDiagnostics, Proteic Bioscience, ProteoMediX, ProterixBio, Provista Diagnostics, Psyche Systems, PTC Therapeutics, PT Elion Medika, Puerto Rico Government, Puma Biotechnology, Q2 Solutions, Qiagen, Quansys Biosciences, Quanterix, QuantumDx, Quantum Leap Health Care Collaborative, Quebec Heart and Lung Institute, Queensland University of Technology, Quest Diagnostics, Qura Therapeutics, Qure Healthcare, Radboud University Nijmegen Medical Centre, Rady Children's Institute for Genomic Medicine, Ragon Institute, Rarecells, Realm IDx, Renegade Bio, Renji Hospital, Repertoire Genesis, Research Center for Molecular Medicine of the Austrian Academy of Sciences, Resolution Bioscience, Reveal Genomics, Rice University, Righton, RNA Disease Diagnostics, Roche, Roche Diagnostics, Rokline Health Concepts, Roswell Biotechnologies, Roswell Park Cancer Institute, Royal College of Surgeons (Ireland), Royal Marsden Hospital, Royal Philips Electronics, RTI International, Rubix LS, SAGA Diagnostics, Sanofi, Sansure Biotech, Saol Therapeutics, Saphetor, Sapphiros, Sarah Cannon Research Institute, Sarepta Therapeutics, Satio, Scipher Medicine, SC Liver Research Consortium (SCLRC), Seaspring, Seattle Children's Hospital, Sebela Pharmaceuticals, Secarna Pharmaceuticals, Seegene, SeekIn, Sekris Biomedical, Selexis, Sema4, SEngine Precision Medicine, Sentinel Diagnostics, SenzaGen, Sepset Biosciences, Seracare Life Sciences, Serosep, Sherlock Biosciences, Shire Human Genetic Therapies, Shuttle Pharmaceuticals, Siemens Healthcare, Siemens Healthineers, Simon Fraser University, Simsen Diagnostics, Singlera Genomics, Singulex, Sino Biological, Siolta Therapeutics, Skane University Hospital, Skyline Diagnostics, SkylineDX, Skysong Innovations, Soma BioScience, SomaLogic, Sona Nanotech, Sonic Healthcare, SOPHiA Genetics, Source Molecular, Spectrum Solutions, SpeeDx, Spesana, Sphingotec, SQI Diagnostics, SRI International, St. Jude Children's Research Hospital, Stanford University, Stanford University School of Medicine, Streck Laboratories, Sumaya Biotech, Sunnybrook Research Institute, Susan G. Komen for the Cure, Swift Biosciences, Swiss Institute of Bioinformatics (SIB), Synexa Life Sciences, Sysmex, Sysmex Inostics, Systec, T-Cure Bioscience, T2 Biosystems, TaiRx, Takara Bio USA, Take2, Takeda Pharmaceutical, Taysha Gene Therapies, Tecan, Tempus, Tesis Biosciences, Texas A&M University, The Binding Site, The Parker Institute For Cancer Immunotherapy, Theralink Technologies, Therma Bright, Thermo Fisher Scientific, ThinkCyte, Thomas Jefferson University, TME Research, Todos Medical, Tokai University, Tolo Biotech, Toronto Innovation Acceleration Partners, Tor Vergata University Hospital, Toyohashi University of Technology, Transcriptome Sciences, Transgenomic, Transplant Genomics, Travera, TrovaGene, True Diagnostics, TScan Therapeutics, TTP Group, Turgut Ilaclari, Twist Bioscience, Tymora Analytical Operations, uBiome, UgenTec, UK Government, UK NEQAS, Ulisse Biomed, Uman Diagnostics, UniQuest, University Ann & Robert H. Lurie Children’s Hospital, University College London, University Health Network, University Hospital Bispebjerg, University Hospital of Leuven, University Medical Center Hamburg-Eppendorf, University of Antwerp, University of Barcelona, University of Birmingham, University of Bonn, University of Bristol, University of California, University of California, San Diego, University of California, San Diego (UCSD) School of Medicine, University of California Berkeley, University of California Irvine, University of California Los Angeles, University of California San Francisco, University of Cambridge, University of Glasgow, University of Greifswald, University of Houston, University of Leeds, University of Leuven, University of Manchester, University of Maryland, Baltimore County, University of Maryland Baltimore, University of Melbourne, University of Miami, University of Michigan, University of Minnesota, University of North Carolina, University of Oxford, University of Pennsylvania, University of Rostock, University of Southampton, University of Surrey, University of Texas Medical Branch, University of Texas Southwestern Medical Center, University of Tubingen, University of Washington, UPMC, Urology Centers of Alabama, Urology San Antonio, USC Norris Comprehensive Cancer Center, US Department of Commerce, US Government, US Oncology, Vanderbilt University, Varian Medical Systems, Vela Diagnostics, Velsera, Ventana Medical Systems, Veracyte, Veravas, Veritas, Verogen, Versea Ophthalmics, Viatar CTC Solutions, VIB, Victoria University, ViennaLab Diagnostics, Vincere Cancer Center, ViraCor Laboratories, Viravaxx, Vir Biotechnology, Visby Medical, VolitionRX, VyGen-Bio, Waseda University, Watchmaker Genomics, Weihai Weigao Medical Devices, Weill Cornell Medical College, Wellcome Trust, WellDyne, Whitman-Walker Institute, Wyss Institute, X4 Pharmaceuticals, XCR Diagnostics, Xencor, Xpedite Diagnostics, XtalPi, Xylonix, Yale University, Yemaachi Biotech, Yesse Technologies, Yitu Medical, Zenyaku Kogyo, Zomedica, zPREDICTA, Zymo Research

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.